Actual - Real Estate

Home loan lending used to be relatively simple. Lenders were so hungry for business they readily accepted no-down mortgages, interest-only loans, and E-Z refinanci

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ng for borrowers with bruised credit. Recently, however, a wave of bad loans wiped out small independent mortgage brokers, devastated bad-credit lenders, and promp

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ed the industry itself to tighten lending practices.

Today, it has become harder than ever for cash-strapped would-be homeowners to obtain home loan lending.

Who

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

Is To Blame?
Experts blame subprime lenders for the recent home loan lending debacle. In the past, people with poor credit scores or large debts and modest i

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

comes would not have been granted a loan. In recent years, however, a new breed of mortgage brokers - called subprime lenders - burst onto the market. Instead of d

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

enying loans to people with poor credit history, they let these people take out mortgages and then charge them higher interest rates to offset the high risks assoc

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ated with the loans.

Such action on the subprime home loan lending front enabled a huge part of the population to own houses. Subprime home loan lending morphed d

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ramatically from a start-up business into a $600-billion-a-year enterprise. The problem with high risks, however, is that they either pay off magnificently or go b

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

st, and this is just what happened. The subprime market fell, and it was not long before homeowners who financed their purchase with subprime loans found themselve

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

s with foreclosure notices in their hands.

Stringent Loan Standards
When applying for home loan lending, expect more than run-of-the-mill scrutiny. The indus

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ry is cracking down on the so-called "liar loans." These are mortgages obtained without verification of the buyer's declared income, under a "stated income loan" o

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

"no documentation loan."

Additionally, the home loan lending industry has become more conservative in attaching value to houses. Before, bankers generously appra

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ised homes for so much more than they're worth. Today, the appraisal is based not on the recent market value of similar homes but on worst-case scenario market pri

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ing. Worst-case scenario value is not the amount a house can be sold for, but the amount it will fetch once it goes into foreclosure.

The Silver Lining
That

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

home loan lending implements stricter regulations is sure to dismay everyone, from borrowers to lenders . However, three good things can come out of this. First, i

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

experienced and even fly-by-night mortgage brokers will be driven out of business, leaving the home loan lending market to legitimate lenders. Second, with lenders

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

no longer eager to grant high-risk loans, there will be more money and better rates for borrowers with sufficient downpayment and good credit. Finally, fewer high

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

risk loans that never should have been granted in the first place will be floated into the market. This will result in fewer homeowners being dismayed and losing t

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

heir homes due to inability to meet payments.

Every story has a moral, and this article contains only one. If something sounds too good to be true, it probably is

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

too good to be true. So when buying a house, do not be tempted to take shortcuts. Go the longer but perfectly legitimate and business-sound home loan lending route

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.actual.org.ua/article/131812/actual-Subprime-Lending--Trojan-Horse-of-the-Home-Loan-Lending-Industry.html">Subprime Lending - Trojan Horse of the Home Loan Lending Industry</a>

BB link (for phorums):
[url=http://www.actual.org.ua/article/131812/actual-Subprime-Lending--Trojan-Horse-of-the-Home-Loan-Lending-Industry.html]Subprime Lending - Trojan Horse of the Home Loan Lending Industry[/url]

Since we all realize life is messy, why does our business websites have to be? I'm not suggesting sloppiness or unprofessional attitudes, simply that it is acceptable to show your humanity through your website.

I recently received an email from an IT contractor friend of mine, Alex, asking for advice on the tricks of the trade when dealing with recruitment agencies. He wanted to know the best way to get agencies to regularly update him and call him. This was my reply...

Since there are so many employers out there these days who want you to email them your resume, you need to make sure that your cover letter has something special to it, otherwise, it will be sent to the trash bin faster than you can say “I’m perfect for the job”.

Tags

Links

Actual - Subprime Lending - Trojan Horse of the Home Loan Lending Industry

Related Articles: